personal scheduler Hamburg 2013 - Main Site Press Release 2013 Call for Abstracts General Information Programme Overview Letter from the President Keynote Lectures Main Sessions NEW - Free Paper Session Instructional Courses World Retina Day Retinal Detachment Course Uveitis Course Other Symposia Surgical Skills Training Courses
hamburg banner

The use of intravitreal bevacizumab (Avastin) before pars plana vitrectomy in patients with proliferative diabetic retinopathy

Session Details

Session Title: Quick Fire Free Paper Session 04

Session Date/Time: Sunday 29/09/2013 | 11:00-13:00

Paper Time: 11:50

Venue: Hall C (Level 1)

First Author: T.Imshenetskaya BELARUS

Co Author(s):    I. Igumnova   V. Yarmak   I. Malinovskaya        

Abstract Details


To evaluate the effectiveness and safety of the using the single injection bevacizumab (Avastin), injected before surgery in patients with proliferative diabetic retinopathy.


Belarusian Medical Academy of Post-Graduate Education, 10th Minsk City Clinical Hospital, Minsk, Belarus


We studied 18 eyes (13 patients): 7 men (54%) and 6 women (46%) with proliferative diabetic retinopathy, average age 46,3. 7 eyes (38,9%), undergoing surgery for nonclearing vitreous hemorrhage and PDR and 16 eyes (88,9%) - severe PDR and tractional retinal detachment. Intravitreal bevacizumab 1.25 mg/0.05 ml was injected 3 to 5 days before vitrectomy. Standard three port vitrectomy was performed using 20 – or 23 – gauge.


13 eyes (72,3%) underwent PPV and gas infusion (SF6). All cases showed minimum bleeding during pars plana vitrectomy. Recurrent vitreous hemorrhage in the early postoperative period was noted only in one eye (5,6%), increasing of the vitreoretinal traction occurred in 3 eyes (16,7%), traction retinal detachment – in one eye (5,6%). Post-operative BCVA improved in 16,7%.


Preoperative use of bevacizumab in the treatment of severe diabetic retinopathy was well tolerated, reduced active neovascularization, that facilitated pars plana vitrectomy, significantly reduced the occurrence of postoperative vitreous hemorrhage."

Back to Freepaper Session
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email:

Privacy policyHotel Terms and Conditions Cancellation policy